Sharda Cropchem Q4 FY25 Results & Concall Highlights: Revenue, Margins & Order Book
Published 26 Aug 2026 | Fertilizers & Agrochemicals | Market Cap: ₹6.9K Cr
Sharda Cropchem is targeting overall top-line growth of 10% to 15% in FY '26. FY '26 Revenue Growth: Targeting 10%-15% top-line growth, driven mainly by volume increases and expected pricing improvement.
From Sharda Cropchem's Q4 FY25 earnings-call transcript · updated 26 Aug 2026.
Price
₹767
Market Cap
₹6.9K Cr
P/E Ratio
11.0
How does Sharda Cropchem rank in Fertilizers & Agrochemicals?
Compare Sharda Cropchem against every Fertilizers & Agrochemicals company this quarter on revenue, margins and earnings-call signals.
Sharda Cropchem — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.1K Cr, net profit ₹319 Cr.
Full financials →📊 Revenue & Sales Performance
- →Sharda Cropchem is targeting overall top-line growth of 10% to 15% in FY '26.
- →Volume growth expectation is stronger, with 10% to 15% growth forecasted for both agrochemical and non-agrochemical segments.
- →Globally, the company’s current 4%-5% global market share offers scope to increase, meaning a 1% global share gain equates to 20%-25% volume growth for them.
- →Regional volume growth in FY '25 was significant: Europe (58%), NAFTA (36%), LatAm (25%).
- →Prices, expected to have pressured margins in FY '25, are forecasted to improve by 10%-15% in FY '26, potentially driving margin expansion.
- →The company is confident despite external pressures like U.S. tariffs due to limited sourcing alternatives globally.
- →Capex for ongoing product registrations is expected to be INR400-450 crores in FY '26, supporting growth.
📈 Profitability & Margins
- →FY '26 Revenue Growth: Targeting 10%-15% top-line growth, driven mainly by volume increases and expected pricing improvement.
- →Volume Growth: Expected 10%-15% growth in both agrochemical and non-agrochemical segments.
- →Margin Expansion: Anticipated EBITDA margin of 15%-18% for FY '26, primarily led by gross margin expansion due to price recovery and improved product mix.
- →Pricing Outlook: Gradual price increases beginning Q1 FY '26 expected, with potential 10%-15% improvement in prices as market normalizes from 2024 oversupply.
- →Profitability: EBITDA and PAT expected to sustain growth trends, with overall positive earnings momentum.
- →Market Share: Focus on increasing global market share from current ~4%-5%, providing scope for higher volume and earnings growth.
- →Operating Efficiencies: Improved working capital cycle and tight inventory management support profitability.
- →No inventory write-offs expected, supporting stable cost management and earnings quality.
🏗️ Capital Expenditure Plans
- →For FY '25, Sharda Cropchem's capex was INR 420 crores.
- →The company is confident in ongoing product registrations.
- →Capex guidance for FY '26 is planned to be in the range of INR 400 crores to INR 450 crores.
- →The capex is aimed at supporting product registrations and business growth.
- →Strategic investments focus on expanding registrations and market share globally.
💰 Fundraising & Capital Structure
- →There is no mention of any current or planned fundraising through debt or equity in the transcript.
- →The company remains net debt-free as of March 31, 2025.
- →Cash, bank balances, and liquid investments stand at INR 558 crores.
- →Capital expenditure (capex) for FY '25 was INR 420 crores, with guidance to maintain capex in the range of INR 400-450 crores in FY '26 for ongoing product registrations.
- →No indication of raising funds through debt or equity was provided during the call or Q&A.
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were Sharda Cropchem Q4 FY25 results?
Sharda Cropchem is targeting overall top-line growth of 10% to 15% in FY '26. FY '26 Revenue Growth: Targeting 10%-15% top-line growth, driven mainly by volume increases and expected pricing improvement.
What is Sharda Cropchem share price analysis?
Sharda Cropchem currently shows a neutral. The stock trades at a P/E of 11.0 with a market cap of ₹6,865 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sharda Cropchem planning capital expenditure?
For FY '25, Sharda Cropchem's capex was INR 420 crores.
Keep Sharda Cropchem on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.